Eric Dillon

Eric Dillon serves as the Sr. Director of Corporate Accounting at Prime Therapeutics since September 2022, overseeing all financial accounting operations and ensuring compliance with financial policies and US GAAP. Prior to this, Eric held various leadership positions, including Sr. Director of Finance Transformation and Finance Director in the Energy Division at CHS Inc., where responsibilities included driving finance transformation initiatives and managing financial reporting and internal controls. Eric's experience also includes roles at SPS Commerce, CHS, UnitedHealth Group, and EY, with a strong focus on accounting policy, financial reporting, and auditing. Eric holds a Master’s Degree in Accounting from the University of Notre Dame and a Bachelor’s Degree in Economics from St. Olaf College.